Nishihara Hiroshi
A novel therapeutic strategy for glioma based on clinicopathological analysis
Experimental Biology 2011.4.9-13, Washington D.C., USA.
M. Tanino, L. Wang, T. Kimura, H. Nishihara, M. Tsuda, Y. Matsuno, K. Okamoto, S. Yano, S. Tanaka
Involvement Of Adaptor Protein Crk In Malignant Features Of Human Mesothelioma
ATS(American Thoracic Society)2011 2011.5.13-18, Denver, Colorado, USA.
S Tanaka, S Kohsaka, L Wang, H Kanno, K Takahashi, T Kimura, M Tanino, H Nishihara, K Nagashima
Analysis of expression mechanism of MGMT in glioblastoma
The 7th Asia Pacific Congress(APIAP 2011) 2011.5.20-24, Taipei, Taiwan.
Hirata Kenji, Hattori Naoya, Shiga Tohru, Usui Reiko, Yamaguchi Shigeru, Terasaka Shunsuke, Narita Takuhito, Tanaka Shinya, Kuge Yuji, Tamaki Nagara
18F-FMISO accumulates un glioblastoma multiforme but not in grade Ⅲor less malignant gliomas.
Society of Nuclear Medicine,58th Anuual Meeting,2011.6.4-8, SanAntonio,Texas,USA.
S Tanaka, SKohsaka, L Wang, H Kanno, K Takahashi, T Kimura, M Tanino, H Nishihara and K Nagashima
Analysis of regulatory mechanism of MGMT expression in glioblastoma
The 2nd Congress of Asian Society of Neuropathology 2011.11.4-6, Beijin, China.
Hiroshi Nishihara, Lei Wang, Mitsufumi Nishio, Tomoyuki Endo, Masato Obara, Katsuya Fujimoto and Shinya Tanaka
Molecular and pathological analysis of DOCK family proteins in hematopoietic malignancy
53rd ASH Annual Meeting and Exposition 2011.12.10-13, San Diego, USA